Kodiak Sciences Inc. SEC filings KOD
Kodiak Sciences Inc. has 422 filings in SEC EDGAR's recent list, going back to Jul 28, 2009. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 2, 2023 | — |
| CORRESP | Letter to the SEC | May 31, 2023 | — |
| UPLOAD | Letter from the SEC | May 22, 2023 | — |
| EFFECT | Filing | May 17, 2023 | — |
| CORRESP | Letter to the SEC | May 15, 2023 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2023 | — |
| EFFECT | Filing | Nov 14, 2019 | — |
| CORRESP | Letter to the SEC | Nov 12, 2019 | — |
| UPLOAD | Letter from the SEC | Nov 12, 2019 | — |
| EFFECT | Filing | Oct 3, 2018 | — |
| CERT | Filing | Oct 2, 2018 | — |
| CORRESP | Letter to the SEC | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Oct 1, 2018 | — |
| 8-A12B | Filing | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Sep 27, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 25, 2018 | — |
| CORRESP | Letter to the SEC | Sep 24, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 17, 2018 | — |
| CORRESP | Letter to the SEC | Sep 14, 2018 | — |
| UPLOAD | Letter from the SEC | May 11, 2018 | — |
| DRSLTR | Filing | Apr 30, 2018 | — |
| DRS/A | Filing | Apr 30, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 13, 2018 | — |
| DRS | Filing | Feb 14, 2018 | — |
| D | Filing | Mar 24, 2016 | — |
| D | Filing | Jul 28, 2009 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KOD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1468748
- Former names
- Oligasis, LLC (until Jul 28, 2009)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.